Agilon Health (NYSE:AGL) Sets New 52-Week High – Still a Buy?

Agilon Health, Inc. (NYSE:AGL)’s share price reached a new 52-week high during trading on Friday . The stock traded as high as $98.60 and last traded at $98.1610, with a volume of 129893 shares changing hands. The stock had previously closed at $95.23.

Wall Street Analyst Weigh In

Several equities analysts recently commented on AGL shares. Weiss Ratings downgraded Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, May 27th. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. TD Cowen reiterated a “hold” rating and issued a $55.00 price objective (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and upped their price objective for the company from $33.00 to $49.00 in a research note on Thursday, May 7th. Finally, Robert W. Baird upped their price objective on Agilon Health from $20.00 to $35.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Five investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $58.73.

Agilon Health Stock Up 1.2%

The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08. The company has a market cap of $1.61 billion, a PE ratio of -4.47 and a beta of 3.02. The stock has a 50-day moving average of $47.53 and a 200-day moving average of $27.47.

Agilon Health (NYSE:AGL) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.04 by $0.76. The company had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. Sell-side analysts predict that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently added to or reduced their stakes in AGL. Goldman Sachs Group Inc. increased its stake in Agilon Health by 196.2% in the fourth quarter. Goldman Sachs Group Inc. now owns 20,055,214 shares of the company’s stock valued at $13,812,000 after acquiring an additional 13,283,930 shares during the last quarter. AQR Capital Management LLC increased its stake in Agilon Health by 1,346.6% in the fourth quarter. AQR Capital Management LLC now owns 10,211,767 shares of the company’s stock valued at $7,033,000 after acquiring an additional 9,505,837 shares during the last quarter. CenterBook Partners LP increased its stake in Agilon Health by 492.4% in the third quarter. CenterBook Partners LP now owns 11,428,027 shares of the company’s stock valued at $11,771,000 after acquiring an additional 9,499,012 shares during the last quarter. North Peak Capital Management LLC increased its stake in Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after acquiring an additional 3,715,460 shares during the last quarter. Finally, Voleon Capital Management LP increased its stake in Agilon Health by 5,519.2% in the third quarter. Voleon Capital Management LP now owns 2,741,039 shares of the company’s stock valued at $2,823,000 after acquiring an additional 2,692,259 shares during the last quarter.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.